Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Understanding adjuvant endocrine therapy persistence (AET) in breast cancer survivors
For most women, decision-making process around AET persistence balancing act between quality of life and quantity of life.
»
07/11/18
Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survival.
Not uncommon to have undetectable PSA 12 or 24 months after a short course of ADT.
»
05/16/18
Hyperglycemia promotes insulin-independent ovarian tumor growth.
Presence of tumor improved impaired glucose tolerance in both Type 1 and Type 2 diabetes.
»
09/11/17
Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells.
Sulphonamides might have potential as new leads for detailed investigations against CA IX-positive cervical cancers.
»
07/14/18
Compromised vitamin D receptor signalling in malignant melanoma is associated with tumour progression and mitogen-activated protein kinase activity.
High MAPK activity in tumours expressing cytoplasmic VDR associated with worsened prognosis.
»
07/14/18
Black-White Breast Cancer Incidence Trends: Effects of Ethnicity.
Incidence rates highest for NHW women.
»
02/23/18
Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8
+
T cell response in esophageal squamous cell carcinoma.
Combining T cell-based therapy with dual PD-1/PD-L1 and TGF-β signaling pathway blockade could be promising strategy.
»
02/09/18
Therapeutic targeting of the pre-metastatic stage in human brain metastasis.
In vivo treatment with Apomorphine prevented BM formation.
»
06/29/18
Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.
IRAK2 rs779901 C>T may be promising prognostic biomarker for NSCLC OS.
»
09/14/17
Erbin suppresses KSR1-mediated RAS/RAF signaling and tumorigenesis in colorectal cancer.
Erbin as negative regulator of tumor initiation and progression.
»
07/02/18
< Prev
Next >